Christopher Norman Andrews

All filings by Christopher Norman Andrews on record concern M Pharmaceutical Inc. We count 2 filings; the first trade dates from 14 May 2015 and the latest from 7 September 2016.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The record was last updated on 11 September 2016 with a transaction in M Pharmaceutical Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.